Search research articles
Contact Us
Filters
Showing results (401-410 of 452) with videos related to
Page
of 46
Sort By:
American Journal of Translational Research
|
October 15, 2021
ITIH5 shows tumor suppressive properties in cervical cancer cells grown as multicellular tumor spheroids
Ann-Kathrin Daum, Jessica Dittmann, Lars Jansen, et al.
Cancers
|
September 14, 2024
Accuracy of GynTect<sup>®</sup> Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3: A Proof-of-Concept Case-Control Study
Heike Hoyer, Cornelia Scheungraber, Grit Mehlhorn, et al.
Anticancer Research
|
July 23, 1998
Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients
T Levy, I Agoulnik, E N Atkinson, et al.
Oncotarget
|
May 27, 2015
Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status
Matthias Dürst, Heike Hoyer, Christoph Altgassen, et al.
International Journal of Cancer
|
July 4, 2017
Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer
Daniel Kritsch, Franziska Hoffmann, Daniel Steinbach, et al.
Journal of the National Cancer Institute
|
July 18, 2013
Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial
Volker Moebus, Christian Jackisch, Andreas Schneeweiss, et al.
Archives of Gynecology and Obstetrics
|
March 22, 2022
The significance of transcervical ultrasound-guided radiofrequency ablation in the treatment of symptomatic fibroids: results of an expert consensus from German-speaking countries
Thomas Römer, Ralf Bends, Ladina Christoffel, et al.
Journal of the National Cancer Institute
|
March 4, 2014
Response
Volker Moebus, Christian Jackisch, Andreas Schneeweiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2001
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer
A Reles, W H Wen, A Schmider, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2017
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial
V Möbus, C Jackisch, H J Lück, et al.
Page
of 46
Search research articles
Search
Showing results (401-410 of 452) with videos related to
Sort By:
Page
of 46
American Journal of Translational Research
|
October 15, 2021
ITIH5 shows tumor suppressive properties in cervical cancer cells grown as multicellular tumor spheroids
Ann-Kathrin Daum, Jessica Dittmann, Lars Jansen, et al.
Cancers
|
September 14, 2024
Accuracy of GynTect<sup>®</sup> Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3: A Proof-of-Concept Case-Control Study
Heike Hoyer, Cornelia Scheungraber, Grit Mehlhorn, et al.
Anticancer Research
|
July 23, 1998
Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients
T Levy, I Agoulnik, E N Atkinson, et al.
Oncotarget
|
May 27, 2015
Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status
Matthias Dürst, Heike Hoyer, Christoph Altgassen, et al.
International Journal of Cancer
|
July 4, 2017
Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer
Daniel Kritsch, Franziska Hoffmann, Daniel Steinbach, et al.
Journal of the National Cancer Institute
|
July 18, 2013
Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial
Volker Moebus, Christian Jackisch, Andreas Schneeweiss, et al.
Archives of Gynecology and Obstetrics
|
March 22, 2022
The significance of transcervical ultrasound-guided radiofrequency ablation in the treatment of symptomatic fibroids: results of an expert consensus from German-speaking countries
Thomas Römer, Ralf Bends, Ladina Christoffel, et al.
Journal of the National Cancer Institute
|
March 4, 2014
Response
Volker Moebus, Christian Jackisch, Andreas Schneeweiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2001
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer
A Reles, W H Wen, A Schmider, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2017
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial
V Möbus, C Jackisch, H J Lück, et al.
Page
of 46